{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:00:59Z","timestamp":1765040459607,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ghir.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T05:46:53Z","timestamp":1378878413000},"page":"249-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation"],"prefix":"10.1016","volume":"23","author":[{"given":"Mariam","family":"Elbornsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina","family":"G\u00f6therstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt-\u00c5ke","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2013.09.001_bb0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1530\/eje.0.1440569","article-title":"Radiotherapy for non-functioning pituitary adenomas","volume":"144","author":"Boelaert","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2013.09.001_bb0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2265.1998.00393.x","article-title":"Radiotherapy for non-function pituitary tumours","volume":"48","author":"Gittoes","year":"1998","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2013.09.001_bb0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2265.1999.00854.x","article-title":"Pituitary adenoma radiotherapy\u2014when, who and how?","volume":"51","author":"Plowman","year":"1999","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2013.09.001_bb0020","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1210\/jc.2011-0306","article-title":"Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis","volume":"96","author":"Appelman-Dijkstra","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. A","key":"10.1016\/j.ghir.2013.09.001_bb0025","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ghir.2006.03.002","article-title":"Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement","volume":"16","author":"Darzy","year":"2006","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2013.09.001_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11102-006-6042-4","article-title":"Hypopituitarism as a consequence of brain tumours and radiotherapy","volume":"8","author":"Darzy","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.ghir.2013.09.001_bb0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1530\/eje.1.02209","article-title":"Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database","volume":"155","author":"Maiter","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2013.09.001_bb0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.clon.2004.01.012","article-title":"Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life","volume":"16","author":"Noad","year":"2004","journal-title":"Clin. Oncol. (R. Coll. Radiol)"},{"key":"10.1016\/j.ghir.2013.09.001_bb0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2265.1997.1600971.x","article-title":"The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease","volume":"46","author":"Peace","year":"1997","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2013.09.001_bb0050","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1667\/RR1903.1","article-title":"Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study","volume":"174","author":"Armstrong","year":"2010","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ghir.2013.09.001_bb0055","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/1097-0142(19890615)63:12<2404::AID-CNCR2820631205>3.0.CO;2-3","article-title":"Incidence of cerebral infarction after radiotherapy for pituitary adenoma","volume":"63","author":"Flickinger","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ghir.2013.09.001_bb0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archneur.1989.00520400109029","article-title":"The effect of radiation on carotid arteries. a review article","volume":"46","author":"Murros","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ghir.2013.09.001_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism","volume":"46","author":"Bulow","year":"1997","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2013.09.001_bb0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2013.09.001_bb0075","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy","volume":"89","author":"Svensson","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2013.09.001_bb0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2013.09.001_bb0085","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1200\/JCO.2008.16.3527","article-title":"Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study","volume":"26","author":"Garmey","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ghir.2013.09.001_bb0090","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-12-1083","article-title":"Fifteen years of growth hormone (GH) replacement improves body composition and cardiovascular risk factors","author":"Elbornsson","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2013.09.001_bb0095","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"Ho","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2013.09.001_bb0100","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2013.09.001_bb0105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/bmj.1.4758.559","article-title":"Antirheumatic effects of hydrocortisone (free alcohol), hydrocortisone acetate, and cortisone (free alcohol) as compared with cortisone acetate; results from oral administration in patients with rheumatoid arthritis","volume":"1","author":"Boland","year":"1952","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ghir.2013.09.001_bb0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2265.1997.3271123.x","article-title":"Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults","volume":"47","author":"Johannsson","year":"1997","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2013.09.001_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.1.02317","article-title":"Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency","volume":"156","author":"Gotherstrom","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2013.09.001_bb0120","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/ajcn\/51.6.1106","article-title":"Dual-energy x-ray absorptiometry for total-body and regional bone\u2013mineral and soft-tissue composition","volume":"51","author":"Mazess","year":"1990","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ghir.2013.09.001_bb0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/00365518009101869","article-title":"Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age","volume":"40","author":"Bruce","year":"1980","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.ghir.2013.09.001_bb0130","first-page":"53","article-title":"Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study","volume":"60","author":"Brabant","year":"2003","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2013.09.001_bb0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1994.tb02556.x","volume":"41","author":"Landin-Wilhelmsen","year":"1994","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2013.09.001_bb0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1365-2265.1997.1851001.x","article-title":"Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test","volume":"46","author":"Svensson","year":"1997","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2013.09.001_bb0145","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1210\/jc.2006-1487","article-title":"A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults","volume":"92","author":"Gotherstrom","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2013.09.001_bb0150","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","article-title":"A prospective study of 5years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices","volume":"86","author":"Gotherstrom","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2013.09.001_bb0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ghir.2013.09.001_bb0160","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.1995.75.3.473","article-title":"Pathophysiology of insulin resistance in human disease","volume":"75","author":"Reaven","year":"1995","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ghir.2013.09.001_bb0165","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2013.09.001_bb0170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ghir.2007.05.005","article-title":"Management of growth hormone deficiency in adults","volume":"17","author":"Nilsson","year":"2007","journal-title":"Growth Hormon. IGF Res."}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637413000920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637413000920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:47:50Z","timestamp":1761086870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637413000920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1096637413000920"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2013.09.001","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}